Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduning Injection for hand-foot-mouth disease with nervous system involvement
ChiCTR-IPR-14005376Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Apr 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Reduning in hand, foot, and mouth disease (HFMD) (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: Time to stable disease condition. Started Apr 2014; status: recruiting.
02
Drugs
Reduning
03
Conditions
hand, foot, and mouth disease (HFMD)
Beyond the preview
Go deeper on ChiCTR-IPR-14005376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005376.